ClinicalTrials.gg
Not yet recruitingNCT07947771GI-ADHDUpdated Nov 19, 2026

Low-glycemic Index Diet and ADHD.

An interventional study of Low glycemic index diet in ADHD - Attention Deficit Disorder With Hyperactivity, sponsored by Kafrelsheikh University. Not yet recruiting. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
6 Years to 18 Years
Sex
All
01

Study summary

This randomized controlled trial will evaluate the effect of a low glycemic index (GI) diet on symptoms of attention deficit hyperactivity disorder (ADHD) in children and adolescents. A total of 128 participants aged 6 to ≤18 years, diagnosed with ADHD according to the Conners Parent Rating Scale-48 (CPRS-48), will be recruited from the pediatric neurology outpatient clinic at Kafrelsheikh University Hospital and randomly assigned in equal numbers (64 per group) to one of two arms. The intervention group will receive a structured low-GI diet (whole grains, legumes, low-GI non-starchy vegetables and fruits, and lean proteins, with refined flour, white rice, and sugary snacks limited) delivered through the Clinical Nutrition Unit, supported by a low-GI pyramid teaching tool, regular dietary counseling, and weekly dietitian review of 3-day food records to monitor adherence. The control group will continue a normal diet. ADHD symptoms will be assessed with the Conners 48 scale at baseline, 1 month, and 6 months. Children with other neurological conditions, autism spectrum disorder, intellectual disability, severe psychiatric conditions, chronic illnesses, diabetes, celiac disease, or food allergies requiring dietary restrictions will be excluded. Written informed consent will be obtained from parents or guardians, and the study has ethics committee approval (REC-KFSIRB200, Kafrelsheikh University).

Suggested additional fields

Primary outcome: Change in Conners 48 score from baseline to 1 and 6 months Study type / design: Interventional; parallel-group randomized controlled trial; prospective Intervention type: Dietary supplement/behavioral (dietary intervention)

Read the detailed description

Background and rationale

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder of childhood and adolescence, characterized by persistent inattention, hyperactivity, and impulsivity. It affects an estimated 3.4% of children and youth worldwide and places a considerable burden on the individual, family, and society, with consequences that include educational difficulties, strained peer relationships, accidental injuries, and substance misuse. Medication and behavioral therapy are the most effective established treatments, but diet is a modifiable environmental factor that has been explored as a complementary approach. The glycemic index (GI) ranks foods by their effect on blood glucose (low GI: under 55; medium: 55 to 70; high: above 70). It has been proposed that a low-GI diet, by providing a steady supply of glucose to the brain together with nutrients needed for neurotransmitter production, may stabilize blood glucose, improve cognitive performance, and reduce behavioral swings. No previous studies were identified that specifically examine the effect of a low-GI diet on ADHD in children, and clinical research is needed to confirm whether it is effective.

Objective

To explore the effect of a low-GI diet on ADHD symptoms in children and adolescents.

Study design

This is a prospective, interventional, parallel-group randomized controlled trial with two arms. The study will be conducted at the pediatric neurology outpatient clinic of Kafrelsheikh University Hospital, and the dietary intervention will be delivered at the outpatient clinic of the Clinical Nutrition Unit of the same hospital.

Sample size

No prior data were available, so a moderate effect size (Cohen's d = 0.5) was assumed. Using G*Power 3.1.9.7 for a two-tailed independent-samples t-test, with 80% power and a 5% significance level, the required sample size was 128 participants (64 per group).

Participants

128 children and adolescents aged 6 to 18 years with ADHD diagnosed using the Conners Parent Rating Scale-48 (CPRS-48).

Inclusion criteria:

Diagnosis of ADHD according to the Conners 48 scale Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion criteria:

Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children

Interventions

Group I (intervention, n = 64): Participants will follow a structured low-GI diet based on a Low-GI Pyramid used as a teaching tool. The diet emphasizes whole grains (e.g., oats, barley), legumes (e.g., lentils, beans), non-starchy vegetables and fruits with a GI below 55, and lean proteins, while limiting high-GI foods such as refined flour, white rice, and sugary snacks. Compliance will be monitored through weekly dietitian review of 3-day food records. Regular dietary counseling sessions with parents will reinforce adherence and resolve problems as they arise.

Group II (control, n = 64): Participants will continue their normal diet.

Assessments

All participants will undergo:

Complete history taking (presenting symptoms, onset, duration, impact across settings, family, developmental, medical, and school history) Complete systemic clinical examination (heart, chest, abdomen, and general examination) Comprehensive nutritional assessment, including dietary history, anthropometric measurements (weight, height, BMI, and their Z-scores), and a nutrition-focused physical examination to rule out signs of micronutrient deficiency ADHD symptom assessment using the Conners Parent Rating Scale-48 at baseline, 1 month, and 6 months

Outcome measures

The primary outcome is the change in Conners 48 score from baseline to 1 month and 6 months, compared between the low-GI diet group and the control group. Dietary adherence, based on 3-day food records, is monitored throughout.

Statistical analysis

Data will be analyzed with statistical software using appropriate methods and presented in tables and graphs.

Ethics

The study has been approved by the Scientific Research Ethics Committee, Kafrelsheikh University (REC-KFSIRB200). Written informed consent will be obtained from the parents or guardians of each child before data collection begins.

02

Conditions studied

  • ADHD - Attention Deficit Disorder With Hyperactivity
03

In context

Attention Deficit Disorder with Hyperactivity

1,818 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 295 are open to participants now.

This study's planned enrollment of 128 is above the median of 71 across 1,437 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Kafrelsheikh University is the lead sponsor of 303 studies on the registry; 120 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of ADHD according to the Conners Parent Rating Scale-48 (CPRS-48) Age 6 to 18 years Not currently on a special diet Caregivers willing to adhere to the dietary intervention

Exclusion criteria

Exclusion Criteria:

  • Other neurological antecedents (such as epilepsy or febrile seizures) Comorbid autism spectrum disorder, intellectual disability, or severe psychiatric conditions Chronic illness (hepatic, renal, or cardiac dysfunction), diabetes, celiac disease, or food allergies requiring dietary restrictions Syndromic children
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Low glycemic index diet.

    Children and adolescents with ADHD (n = 64) follow a structured low-GI diet based on a Low-GI Pyramid teaching tool: whole grains, legumes, low-GI non-starchy vegetables and fruits (GI below 55), and lean proteins, limiting refined flour, white rice, and sugary snacks. Regular dietary counseling sessions and weekly dietitian review of 3-day food records support adherence.

    Dietary Supplement: Low glycemic index diet

  • No intervention
    Normal diet (control).

    Children and adolescents with ADHD (n = 64) continue their usual diet.

Interventions

  • Dietary supplementLow glycemic index diet

    Structured low-GI diet with dietary counseling and weekly review of 3-day food records. Linked arm: Arm 1

06

What researchers measure

Primary outcomes

  1. Change in ADHD symptom severity.

    Change in total score on the Conners Parent Rating Scale-48 (CPRS-48), completed by parents or caregivers. The change from baseline is compared between the low glycemic index diet group and the normal diet group. Higher scores indicate more severe symptoms.

    Time frame: Baseline, 1 month, and 6 months.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Jun 1;57(11):1313-23. doi: 10.1016/j.biopsych.2004.11.024. Epub 2005 Jan 21. PubMed 15950004 ↗
  • Del-Ponte B, Quinte GC, Cruz S, Grellert M, Santos IS. Dietary patterns and attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. J Affect Disord. 2019 Jun 1;252:160-173. doi: 10.1016/j.jad.2019.04.061. Epub 2019 Apr 10. PubMed 30986731 ↗
  • Cruikshank BM, Eliason M, Merrifield B. Long-term sequelae of cold water near-drowning. J Pediatr Psychol. 1988 Sep;13(3):379-88. doi: 10.1093/jpepsy/13.3.379. No abstract available. PubMed 3199295 ↗
  • Coghill D, Hodgkins P. Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls. Eur Child Adolesc Psychiatry. 2016 Mar;25(3):261-71. doi: 10.1007/s00787-015-0728-y. Epub 2015 Jun 9. PubMed 26054300 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

Of 480 non-industry interventional studies with no phase under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 7 months is below that.

Counting every sponsor, half of 511 studies reached it within 23 months; a quarter within 11 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 19, 2026
StartEst.
Nov 30, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jul 31, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07947771
Responsible party
Shimaa Shaker Attia Gafar (Resident., Kafrelsheikh University) — Principal investigator
First posted
Nov 19, 2026
Start date
Nov 30, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Shimaa Gaffar, Resident
Contact
shimaashaker49@gmail.com
+2001060532269

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion